SlideShares tagged with biosimilar
-
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf
Yaohai Bio-pharmaceutical Overview_Jason 202212V2.pdf1y ago, 48 views
1y ago, 48 views -
Biosimilar.pptx
Biosimilar.pptx1y ago, 49 views
1y ago, 49 views -
biosimilar-intended copies--mohie.pdf
biosimilar-intended copies--mohie.pdf1y ago, 43 views
1y ago, 43 views -
CDSCO PAC Application PPT.pdf
CDSCO PAC Application PPT.pdf1y ago, 202 views
1y ago, 202 views -
Biosimilars :A New Horizon in Ocular Therapeutics.
Biosimilars :A New Horizon in Ocular Therapeutics.2y ago, 104 views
2y ago, 104 views -
Comparision biologics & biosimilar
Comparision biologics & biosimilar3y ago, 26 views
3y ago, 26 views -
Biosimilars and regulatory requirements for approval.
Biosimilars and regulatory requirements for approval.4y ago, 455 views
4y ago, 455 views -
Improving africa healthcare landscape
Improving africa healthcare landscape4y ago, 92 views
4y ago, 92 views -
Krabeva
Krabeva5y ago, 189 views
5y ago, 189 views -
PEPGENE Pitch Deck
PEPGENE Pitch Deck5y ago, 1,342 views
5y ago, 1,342 views -
Biosimilars
Biosimilars5y ago, 16,277 views
5y ago, 16,277 views -
Regulation of biosimilar in India
Regulation of biosimilar in India5y ago, 2,508 views
5y ago, 2,508 views -
Biosimilars: A U.S. Perspective
Biosimilars: A U.S. Perspective5y ago, 84 views
5y ago, 84 views -
Generic Drugs and Biosimilars
Generic Drugs and Biosimilars5y ago, 923 views
5y ago, 923 views -
What’s In a Name? FDA and Non-Proprietary Names for Biologics/Biosimilars
What’s In a Name? FDA and Non-Proprietary Names for Biologics/Biosimilars6y ago, 732 views
6y ago, 732 views -
Eval grade eca 24w, ar adalim [bsm vs marc], =mej acr20 =ea =inmun
Eval grade eca 24w, ar adalim [bsm vs marc], =mej acr20 =ea =inmun6y ago, 2,514 views
6y ago, 2,514 views -
FDA Regulation of Biosimilars
FDA Regulation of Biosimilars6y ago, 241 views
6y ago, 241 views -
ANDAs, OTCs, and Orphan Drugs
ANDAs, OTCs, and Orphan Drugs6y ago, 288 views
6y ago, 288 views
